Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

Autor: van den Bent, MJ, Wefel, JS, Schiff, D, Taphoorn, MJB, Jaeckle, K, Junck, L, Armstrong, T, Choucair, A, Waldman, AD, Gorlia, T, Chamberlain, M, Baumert, BG, Vogelbaum, MA, Macdonald, DR, Reardon, DA, Wen, PY, Chang, SM, Jacobs, AH

Publikováno v: In Lancet Oncology 2011 12(6):583-593

Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy

Autor: Berent, S, Giordani, B, Gilman, S, Trask, C.L, Little, R.J.A, Johanns, J.R, Junck, L, Kluin, K.J, Heumann, M, Koeppe, R.A

Publikováno v: In Brain and Cognition 2002 50(2):194-206

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Autor: Weller, M, Butowski, N, Tran, DD, Recht, LD, Lim, M, Hirte, H, Ashby, L, Mechtler, L, Goldlust, SA, Iwamoto, F, Drappatz, J, O'Rourke, DM, Wong, M, Hamilton, MG, Finocchiaro, G, Perry, J, Wick, W, Green, J, He, Y, Turner, CD, Yellin, MJ, Keler, T, Davis, TA, Stupp, R, Sampson, JH, Campian, J, Recht, L, Goldlust, S, Becker, K, Barnett, G, Nicholas, G, Desjardins, A, Benkers, T, Wagle, N, Groves, M, Kesari, S, Horvath, Z, Merrell, R, Curry, R, O'Rourke, J, Schuster, D, Mrugala, M, Jensen, R, Trusheim, J, Lesser, G, Belanger, K, Sloan, A, Purow, B, Fink, K, Raizer, J, Schulder, M, Nair, S, Peak, S, Brandes, A, Mohile, N, Landolfi, J, Olson, J, Jennens, R, DeSouza, P, Robinson, B, Crittenden, M, Shih, K, Flowers, A, Ong, S, Connelly, J, Hadjipanayis, C, Giglio, P, Mott, F, Mathieu, D, Lessard, N, Sepulveda, SJ, Lövey, J, Wheeler, H, Inglis, PL, Hardie, C, Bota, D, Lesniak, M, Portnow, J, Frankel, B, Junck, L, Thompson, R, Berk, L, McGhie, J, Macdonald, D, Saran, F, Soffietti, R, Blumenthal, D, André de, SBCM, Nowak, A

Publikováno v: Weller, M; Butowski, N; Tran, DD; Recht, LD; Lim, M; Hirte, H; et al.(2017). Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. The Lancet Oncology, 18(10), 1373-1385. doi: 10.1016/S1470-2045(17)30517-X. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2sg9m5wp

© 2017 Elsevier Ltd Background Rindopepimut (also known as CDX-110), a vaccine targeting the EGFR deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet haemocyanin. In the ACT IV study, we aimed to assess

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::6bdef254233643727bdc6e1e7e8761af
http://www.escholarship.org/uc/item/2sg9m5wp

Ab uno disce omnes. Che genere di dizionario?

Autor: Cacciapuoti, G, Milella, A, Cruciani, M, Baldo, D, Tomarchio, V, Marsico, S, Sulis, Mc, Nocentini, M, Arena, P, Capasso, L, Boaretto, N, Giacobbe, I, Belotti, B, Oliva, R, Onnis, A, Spnelli, P, Rizzo, E, Minoli, L, Basile, G, Anatra, Mg, Cerkvenic, E, Antolini, C, Ocanha, Sv, Tomasucci, R, Cario, N, Gallarate, M, Pilò, C, Giaccai, S, Cavagnoli, S, Metta, L, Strickland, E, Laterza, R, Priulla, G, Ianniciello, C, Belardi, A, Lanzon, P, Clemente, A, Fedeli, V, Marchetti, C, Miceli, E, Milito, D, Junck, L, Candiani, L, Guerrieri, L, Casilio, S, Vitelli, F, Chersi, M, Coppola, A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3667::037457d8d7e4cfd2b178b7b46999eb9b
http://hdl.handle.net/2108/190042

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.